课题基金 / 基金详情

Facilitating cartilage regeneration by heterogeneous progenitor cells

Facilitating cartilage regeneration by heterogeneous progenitor cells
通过异质祖细胞促进软骨再生
批准号:
8530951
负责人:
Ryan Michael Porter
金额:
$22.98万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2014-12-31

项目摘要

项目成果

Ryan Michael Porter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Current standards of care for cartilage injuries cannot reliably provide sustained clinical improvement, so there is much interest in the development of alternative, biological approaches towards repair/regeneration. Regenerative medicine approaches typically involve the recruitment or transplantation of endogenous mesenchymal progenitor cells (MFCs) to the defect site. Under controlled conditions, these cells have the potential to proliferate, differentiate along the relevant musculoskeletal lineage and regenerate damaged tissue matrix. However, the intra-articular environment can be hostile to chondrogenesis; specifically, inflammation within the injured joint can inhibit tissue regeneration. Joint inflammation is mediated locally by cytokines such as interleukin-1 and tumor necrosis factor-a. Although proinflammatory cytokines play an important role in the pathogenesis of osteoarthritis, little is known about how they affect cartilage repair strategies involving MFCs. The central hypothesis shaping this project is that inflammation secondary to joint trauma or subsequent surgical intervention can inhibit the regenerative activity of MFCs within the cartilage defect, thus limiting repair. During the mentored phase, a toolset of reporter constructs were developed for monitoring the state of human MFC differentiation, using these constructs to non-invasively track inflammatory and chondrogenic activity within an immunocompromised rat model of cartilage injury. Upon transition to the independent phase of the project, tools developed during the mentored phase will help characterize the proinflammatory environment resulting from surgically-induced joint trauma, identifying factors that impair chondrogenesis and defect repair. Both immunologically-competent and -incompetent animal models of joint injury will be used to determine the ability of MFCs to repair/regenerate cartilage when protected from the identified factors. At the end of this project period, we will have a better understanding of how the joint environment - particularly inflammatory signaling - impacts the ultimate success of cartilage regeneration strategies using heterogeneous progenitor cell populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extracellular vesicles as therapeutic vehicles for chondroprotection
  • 批准号:
    10117408
  • 项目类别:
  • 资助金额:
    $30.08万
  • 财政年份:
    2019
  • 负责人:
    Ryan Michael Porter
  • 依托单位:
Extracellular vesicles as therapeutic vehicles for chondroprotection
  • 批准号:
    10357781
  • 项目类别:
  • 资助金额:
    $31.05万
  • 财政年份:
    2018
  • 负责人:
    Ryan Michael Porter
  • 依托单位:
Extracellular vesicles as therapeutic vehicles for chondroprotection
  • 批准号:
    10268960
  • 项目类别:
  • 资助金额:
    $30.06万
  • 财政年份:
    2018
  • 负责人:
    Ryan Michael Porter
  • 依托单位:
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo
  • 批准号:
    9592522
  • 项目类别:
  • 资助金额:
    $1.56万
  • 财政年份:
    2017
  • 负责人:
    Ryan Michael Porter
  • 依托单位:
海外基金